Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | Potassium Phosphate, Tribasic | HCID 62657 | — |
| Reactant | N,N-Dimethylethylenediamine | HCID 66053 | — |
| Reactant | 2-Bromo-6-fluoropyridine | HCID 639438 | — |
| Reactant | HCID 72714886 | HCID 72714886 | — |
| Catalyst | Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI) | HCID 24350 | — |
| Product | HCID 72714885 | HCID 72714885 | 37% |
Reaction Steps
Copper (I) iodide (0.011 g, 0.057 mmol) was added to a stirred suspension of 2-(benzyloxy)-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-4-one (0.3 g, 1.16 mmol), 2-bromo-6-fluoropyridine (0.25 g, 1.42 mmol), N,N-dimethylethylenediamine (0.02 g, 0.23 mmol) and K3PO4 (0.5 g, 2.36 mmol) in 1,4-dioxane (15 mL). The reaction mixture was stirred at 80° C. for 16 hours and then the solvent was evaporated in vacuo. The mixture was diluted with water and extracted with DCM. The organic layer was separated, dried (Na2SO4), filtered and the solvents evaporated in vacuo. The crude product was purified by preparative-HPLC (Gemini 250 Å×20 mm, gradient ACN in water from 40% to 70% with 0.05% NH4OH in water) to yield 2-(benzyloxy)-5-(5-fluoropyridin-2-yl)-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-4-one (0.151 g, 37% yield). C19H12FN4O2. 1H NMR (400 MHz, CDCl3) δ ppm 2.40 (quin, J=6.7 Hz, 2H), 4.18 (t, J=6.3 Hz, 2H), 4.35 (t, J=6.9 Hz, 2H), 5.21 (s, 2H), 6.28 (s, 1H), 7.30-7.42 (m, 3H), 7.43-7.50 (m, 3H), 8.12 (dd, J=9.3, 4.0 Hz, 1H), 8.26 (d, J=3.0 Hz, 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08901125B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-40f865fb0b8f4d62912f409e9c347041 |
|---|
| Source note | uspto-grants-2014_12 |
|---|